sr 33557 has been researched along with Muscle Contraction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fraser, S; Kenny, BA; Spedding, M | 1 |
| Bois, P; Lazdunski, M; Romey, G | 1 |
2 other study(ies) available for sr 33557 and Muscle Contraction
| Article | Year |
|---|---|
Identification of a novel calcium antagonist binding site in rat brain by SR 33557.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Binding Sites; Calcium Channel Blockers; Cations, Divalent; Cations, Monovalent; Cecum; Cerebral Cortex; Dihydropyridines; Female; Guinea Pigs; Indolizines; Male; Muscle Contraction; Muscle, Smooth; Phenethylamines; Rats; Rats, Sprague-Dawley | 1993 |
Indolizinsulphones. A class of blockers with dual but discriminative effects on L-type Ca2+ channel activity and excitation-contraction coupling in skeletal muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Action Potentials; Animals; Binding Sites; Calcium Channel Blockers; Calcium Channels; Indolizines; Muscle Contraction; Muscles; Phenethylamines | 1991 |